Cyclophosphamide Enhances Antitumor Efficacy of Oncolytic Adenovirus Expressing Uracil Phosphoribosyltransferase (UPRT) in Immunocompetent Syrian Hamsters

被引：0

作者：

Hasegawa, Naoyuki ^{[1
,2
]}

Abei, Masato ^{[1
]}

Yokoyama, Kazunari K. ^{[3
]}

Fukuda, Kuniaki ^{[1
]}

Seo, Emiko ^{[1
]}

Kawashima, Rei ^{[1
]}

Nakano, Yuri ^{[1
]}

Yamada, Takeshi ^{[1
]}

Nakade, Koji ^{[2
]}

Hamada, Hirofumi ^{[4
]}

Obata, Yuichi ^{[2
]}

Hyodo, Ichinosuke ^{[1
]}

机构：

[1] Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan

[2] RIKEN BioResource Ctr, Div Gene Engn, Tsukuba, Ibaraki, Japan

[3] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan

[4] Tokyo Univ Pharm & Life Sci, Dept Life Sci, Hachioji, Tokyo 19203, Japan

来源：

MOLECULAR THERAPY | 2013年 / 21卷

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

643

引用

页码：S245 / S245

页数：1

共 30 条

[21] Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamsters
Dhar, D.
Toth, K.
Wold, W. S. M.
CANCER GENE THERAPY, 2014, 21 (04) : 171 - 178
[22] Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamsters
D Dhar
K Toth
W S M Wold
Cancer Gene Therapy, 2014, 21 : 171 - 178
[23] Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells
Watanabe, Keisuke
Guedan, Sonia
Scholler, John
McGettigan, Shannon
Luo, Yangpin
Tahtinen, Siri
Parviainen, Suvi
Havunen, Riikka
Siurala, Mikko
Hemminki, Akseli
June, Carl H.
BLOOD, 2016, 128 (22)
[24] Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody
Kanaya, Nobuhiko
Kuroda, Shinji
Kakiuchi, Yoshihiko
Kumon, Kento
Tsumura, Tomoko
Hashimoto, Masashi
Morihiro, Toshiaki
Kubota, Tetsushi
Aoyama, Katsuyuki
Kikuchi, Satoru
Nishizaki, Masahiko
Kagawa, Shunsuke
Tazawa, Hiroshi
Mizuguchi, Hiroyuki
Urata, Yasuo
Fujiwara, Toshiyoshi
MOLECULAR THERAPY, 2020, 28 (03) : 794 - 804
[25] Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
Su, Bing-Hua
Shieh, Gia-Shing
Tseng, Yau-Lin
Shiau, Ai-Li
Wu, Chao-Liang
ONCOTARGET, 2015, 6 (35) : 38308 - 38326
[26] Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer (vol 396, pg 155, 2017)
Jung, Kyung Hee
Choi, Il-Kyu
Lee, Hee-Seung
Yan, Hong Hua
Son, Mi Kwon
Ahn, Hyo Min
Hong, JinWoo
Yun, Chae-Ok
Hong, Soon-Sun
CANCER LETTERS, 2017, 404 : 93 - 93
[27] Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-γ gene yields efficient antitumor activity in immunodeficient and immunocompetent mice
Su, Changqing
Peng, Linhui
Sham, Jonathan
Wang, Xinghua
Zhang, Qi
Chua, Daniel
Liu, Chen
Cui, Zhenfu
Xue, Huibin
Wu, Hongping
Yang, Qin
Zhang, Baihe
Liu, Xinyuan
Wu, Mengchao
Qian, Qijun
MOLECULAR THERAPY, 2006, 13 (05) : 918 - 927
[28] Enhanced Antitumor Efficacy of Oncolytic Adenovirus Co-Expressing IL-12 and shVEGF Combined with Anti-PD-1 in Renal Cell Carcinoma
Kim, Yunlim
Yoon, A-Rum
Yun, Chae-Ok
Kim, Choung-Soo
Lim, Bumjin
CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
[29] Downregulation of ErbB3 Expression by Adenovirus Expressing ErbB3 Specific shRNA Enhances Antitumor Efficacy through Apoptosis Induction
Yoo, Ji Young
Shin, Hye Won
Kim, Joo-Hang
Yun, Chae-Ok
MOLECULAR THERAPY, 2009, 17 : S106 - S106
[30] Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors
Tanoue, Kiyonori
Shaw, Amanda Rosewell
Watanabe, Norihiro
Porter, Caroline
Rana, Bhakti
Gottschalk, Stephen
Brenner, Malcolm
Suzuki, Masataka
CANCER RESEARCH, 2017, 77 (08) : 2040 - 2051

← 1 2 3 →